Analysts Set The Beauty Health Company (NASDAQ:SKIN) PT at $2.40

Shares of The Beauty Health Company (NASDAQ:SKINGet Free Report) have earned a consensus rating of “Reduce” from the seven research firms that are currently covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, four have given a hold recommendation and one has issued a buy recommendation on the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $2.40.

Several brokerages have commented on SKIN. Jefferies Financial Group reiterated a “hold” rating and set a $1.60 target price on shares of Beauty Health in a research note on Wednesday, January 14th. Zacks Research downgraded Beauty Health from a “hold” rating to a “strong sell” rating in a report on Wednesday, January 21st. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Beauty Health in a research report on Friday, October 31st. Wall Street Zen lowered Beauty Health from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Finally, TD Cowen upped their target price on shares of Beauty Health from $1.50 to $1.65 and gave the company a “hold” rating in a research note on Wednesday, January 21st.

Get Our Latest Stock Analysis on SKIN

Beauty Health Price Performance

SKIN opened at $0.94 on Friday. The stock has a 50-day moving average price of $1.38 and a 200-day moving average price of $1.62. The firm has a market cap of $119.85 million, a PE ratio of -4.27 and a beta of 1.16. Beauty Health has a 1 year low of $0.78 and a 1 year high of $2.69. The company has a debt-to-equity ratio of 5.53, a current ratio of 4.98 and a quick ratio of 4.07.

Institutional Investors Weigh In On Beauty Health

A number of large investors have recently added to or reduced their stakes in the stock. Mirabella Financial Services LLP raised its stake in Beauty Health by 21.3% during the 3rd quarter. Mirabella Financial Services LLP now owns 15,596,277 shares of the company’s stock valued at $31,037,000 after buying an additional 2,734,728 shares during the last quarter. Woodline Partners LP grew its holdings in shares of Beauty Health by 255.9% in the third quarter. Woodline Partners LP now owns 5,930,027 shares of the company’s stock worth $11,801,000 after acquiring an additional 4,263,997 shares during the period. Millennium Management LLC increased its position in Beauty Health by 127.0% during the fourth quarter. Millennium Management LLC now owns 5,764,802 shares of the company’s stock valued at $8,013,000 after acquiring an additional 3,225,668 shares during the last quarter. Geode Capital Management LLC increased its position in Beauty Health by 27.5% during the second quarter. Geode Capital Management LLC now owns 2,302,784 shares of the company’s stock valued at $4,399,000 after acquiring an additional 496,963 shares during the last quarter. Finally, State Street Corp lifted its holdings in Beauty Health by 0.9% in the fourth quarter. State Street Corp now owns 1,871,527 shares of the company’s stock valued at $2,601,000 after acquiring an additional 16,493 shares during the period. Institutional investors own 93.26% of the company’s stock.

About Beauty Health

(Get Free Report)

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.

Further Reading

Analyst Recommendations for Beauty Health (NASDAQ:SKIN)

Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.